Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garofolo

At Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garofolo in Trieste, research in Pediatrics focuses strongly on immune system diseases, digestive system diseases, and musculoskeletal diseases. The trials include children with juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, ulcerative colitis, Crohn's disease, and related inflammatory conditions, with the goal of improving disease control and finding better long-term treatment strategies.

• Testing new therapies for pediatric inflammatory bowel disease and arthritis
• Evaluating treatment effectiveness in chronic immune-mediated conditions
• Supporting safer, more personalized care for children in remission

Several studies also explore macrophage activation syndrome and other severe inflammatory complications, reflecting the site's expertise in complex pediatric immunology.

The site has a major research focus on neoplasms and hemic and lymphatic diseases, especially acute lymphoblastic leukemia, lymphoblastic lymphoma, neuroblastoma, osteosarcoma, rhabdomyosarcoma, and acute promyelocytic leukemia. These trials are designed to improve survival, reduce relapse, and refine treatment approaches for children and adolescents with high-risk or relapsed cancers.

• Comparing treatment approaches for newly diagnosed and relapsed leukemia
• Studying new combinations to improve cancer control and survival
• Assessing therapies for high-risk solid tumors in children

Research at the Pediatrics Unit also includes immunotherapy and targeted treatment strategies, showing a strong commitment to more effective and less toxic cancer care.

Clinical trials here also address nutritional and metabolic diseases and genetic phenomena, including obesity, type 1 interferonopathies, Prader-Willi syndrome, White-Sutton syndrome, Turner syndrome, short stature, and PIK3CA-related overgrowth spectrum. The research aims to improve diagnosis, support growth and weight management, and evaluate targeted treatments for rare pediatric conditions.

• Studying therapies for growth failure and short stature
• Evaluating treatments for pediatric obesity and related metabolic risk
• Exploring targeted care for rare genetic overgrowth and syndromic disorders

This area highlights the site's role in advancing precision medicine for children with complex inherited and developmental conditions.

Another important research stream involves respiratory tract diseases, bacterial infections, and related pediatric complications such as respiratory syncytial virus bronchiolitis and urinary tract infections. These trials aim to improve prevention, shorten illness, and identify more effective and practical treatment options for children.

• Evaluating prevention strategies for RSV-related illness in infants
• Testing optimized antibiotic approaches for febrile urinary tract infections
• Improving care for pediatric respiratory and infectious diseases

The research profile at this hospital/clinic/other health care facility shows a broad pediatric portfolio that combines common childhood illnesses with rare and highly specialized conditions.